Completed first phase of contract for $50 million; HHS options to procure up to $31 million of ANTHIM by the first half of 2023 Reaffirms ANTHIM...
0001476963 false 0001476963 2022-01-12 2022-01-12 iso4217:USD xbrli:shares iso4217:USD xbrli:shares ...
DURHAM, N.C., Jan. 12, 2022 (GLOBE NEWSWIRE) -- Heat Biologics, Inc. (“Heat”) (NASDAQ: HTBX), a...
0001476963 false 0001476963 2022-01-04 2022-01-04 iso4217:USD xbrli:shares iso4217:USD xbrli:shares ...
FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...
0001476963 false 0001476963 2021-12-30 2021-12-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares ...
In a report released today, Mayank Mamtani from B.Riley Financial maintained a Buy rating on Heat Biologics (HTBX – Research Report), with a price...
0001476963 false 0001476963 2021-12-20 2021-12-20 iso4217:USD xbrli:shares iso4217:USD xbrli:shares ...
DURHAM, N.C., Dec. 21, 2021 (GLOBE NEWSWIRE) -- Heat Biologics, Inc. (“Heat”) (NASDAQ: HTBX), a...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities...
0001476963 false 0001476963 2021-12-13 2021-12-13 iso4217:USD xbrli:shares iso4217:USD xbrli:shares ...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.